CANCER MARS SHOT FIGHTING CANCER TOGETHER
LIVE

Serial Number

97728483

Owner

Audubon Health Group, LLC

Attorney

Robert Devin Ricci

First Use Date

Dec 21, 2022

Filing Date

Dec 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CANCER MARS SHOT FIGHTING CANCER TOGETHER Trademark

Serial Number: 97728483

CANCER MARS SHOT FIGHTING CANCER TOGETHER is a trademark filed by Audubon Health Group, LLC on December 22, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Audubon Health Group, LLC (5 trademarks)

Suite 200, V112
Houston, TX 77054

Entity Type: 16

Trademark Details

Filing Date

December 22, 2022

Registration Date

Not Registered

First Use Anywhere

December 21, 2022

First Use in Commerce

December 21, 2022

Published for Opposition

March 12, 2024

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting scientific research and scientific research in the nature of conducting clinical trials in the field of oncology and cancer research for others; Providing a website featuring educational information in the field of clinical research; Medical and scientific research, namely, conducting clinical trials for others; Providing medical testing services and information in the field of cancer research and disease classification; technical research and consulting in the field of pharmaceutical studies; Pharmaceutical research services; Pharmaceutical research and development; testing of pharmaceuticals; Biotechnology research; Medical research; DNA analysis services for scientific research purposes; Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; Medical and scientific research in the field of cancer treatment; Providing medical research information in the nature of medical research data pertaining to cancer and its treatment; consulting services for others in the field of project Management of clinical and translational trials in the field of cancer treatment for others in the nature of conducting clinical trials for others; Providing medical and scientific research in formation from clinical trials in the nature of research data pertaining to cancer; consulting services for others in the field of design, planning and implementation of clinical trials, specifically thedevelopment and validation of clinical trials and testsper formed during clinical trials; testing, analysis and evaluation of the clinical trials and tests of others to determine conformity with certification standards; Design,research, development and testing servicesin the field of pharmaceuticals, biobanking, and cancer research for medical and scientific purposes; Preclinical scientific and medical research services in the field of biospecimens collections; Research in the field of artificial intelligence for medical and scientific research purposes

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 10, 2024 ETOP
OPPOSITION INSTITUTED NO. 999999
Jul 10, 2024 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 10, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 5, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 5, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 20, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2023 NWOS
NEW APPLICATION ENTERED
Dec 26, 2022 NWAP